# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-26-036998
Filing Date
2026-08-11
Accepted
2026-08-11 08:45:41
Documents
17
Period of Report
2026-08-11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | formdef14a.htm iXBRL | DEF 14A | 927965
2 | GRAPHIC | formdef14a_001.jpg | GRAPHIC | 4101
3 | GRAPHIC | proxy_001.jpg | GRAPHIC | 474419
4 | GRAPHIC | proxy_002.jpg | GRAPHIC | 395422
| Complete submission text file | 0001493152-26-036998.txt |  | 3623681

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | cdt-20251231.xsd | EX-101.SCH | 3415
6 | XBRL DEFINITION FILE | cdt-20251231_def.xml | EX-101.DEF | 3366
7 | XBRL LABEL FILE | cdt-20251231_lab.xml | EX-101.LAB | 53135
8 | XBRL PRESENTATION FILE | cdt-20251231_pre.xml | EX-101.PRE | 41979
20 | EXTRACTED XBRL INSTANCE DOCUMENT | formdef14a_htm.xml | XML | 3326

Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CDT Equity Inc. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41245 | Film No.: 261260787
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)